Published in Clin Chem on December 01, 1998
Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem (2001) 3.24
False-positive results and the polymerase chain reaction. Lancet (1988) 2.22
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res (1999) 2.19
Prenatal detection of fetal Down's syndrome from maternal plasma. Lancet (2000) 1.97
Detection of single-copy fetal DNA sequence from maternal blood. Lancet (1990) 1.85
Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. Clin Chem (2001) 1.72
Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers. Lancet (1993) 1.71
Presence of fetal RNA in maternal plasma. Clin Chem (2000) 1.45
Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chem (1999) 1.35
Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. J Med Genet (2000) 1.34
Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet (1998) 1.33
Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin Cancer Res (2000) 1.22
Maternal plasma fetal DNA as a marker for preterm labour. Lancet (1998) 1.16
Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem (2001) 1.12
Detection of Plasmodium falciparum DNA in plasma. Ann N Y Acad Sci (2001) 1.12
HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology (1994) 1.10
Transfer of nucleated maternal cells into fetal circulation during the second trimester of pregnancy. Br J Haematol (1998) 1.08
Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. Nat Genet (1992) 1.06
Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol (2000) 1.06
Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: urinary DNA chimerism. Clin Chem (1999) 1.04
High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population. Diabetologia (1996) 0.91
Molecular genetics of diabetes mellitus in Chinese subjects: identification of mutations in glucokinase and hepatocyte nuclear factor-1alpha genes in patients with early-onset type 2 diabetes mellitus/MODY. Diabet Med (1999) 0.91
Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients. Clin Chem (2000) 0.89
Presence of mitochondrial tRNA(Leu(UUR)) A to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus. J Clin Pathol (2000) 0.85
Epigenetic tumor markers in plasma and serum: biology and applications to molecular diagnosis and disease monitoring. Ann N Y Acad Sci (2001) 0.85
HLA typing by double ARMS. Lancet (1991) 0.85
Adiabatic compressibility of myoglobin. Effect of axial ligand and denaturation. Biochim Biophys Acta (1986) 0.84
Circulating fetal RNA in maternal plasma. Ann N Y Acad Sci (2001) 0.83
Fetomaternal cellular and plasma DNA trafficking: the Yin and the Yang. Ann N Y Acad Sci (2001) 0.83
Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma. Clin Chem (1999) 0.82
Determination of fetal RhD status by maternal plasma DNA analysis. Ann N Y Acad Sci (2000) 0.82
Tumor-derived epigenetic changes in the plasma and serum of liver cancer patients. Implications for cancer detection and monitoring. Ann N Y Acad Sci (2000) 0.82
Detection of mammaglobin mRNA in the plasma of breast cancer patients. Ann N Y Acad Sci (2001) 0.81
Derivation of a prediction rule for posttraumatic organ failure using plasma DNA and other variables. Ann N Y Acad Sci (2001) 0.81
Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis. J Clin Pathol (1994) 0.81
Screening for codon 249 p53 mutation in lung cancer associated with domestic radon exposure. Lancet (1995) 0.81
Molecular testing of urine: catching DNA on the way out. Clin Chem (2000) 0.80
Detection of hepatitis B pre-core mutant by allele specific polymerase chain reaction. J Clin Pathol (1992) 0.80
Culture of fetal erythroid cells from maternal peripheral blood. Lancet (1994) 0.80
Assessment of trans fatty acids content in popular Western-style products in China. J Food Sci (2008) 0.79
Failure to detect cytomegalovirus DNA in pancreas in type 2 diabetes. Lancet (1992) 0.79
Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma. Br J Haematol (1995) 0.79
Detection of susceptibility alleles to insulin-dependent diabetes mellitus at the DQB1 locus by artificial PCR-RFLP. Immunogenetics (1992) 0.78
Linkage analysis of maturity-onset diabetes of the young with microsatellite polymorphisms. No linkage to ADA or GLUT2 genes in two families. Diabetes (1992) 0.78
Recovery of nicotine-free proteins from tobacco leaves using phosphate buffer system under controlled conditions. Bioresour Technol (2009) 0.77
Cell-free fetal deoxyribonucleic acid in maternal circulation as a marker of fetal-maternal hemorrhage in patients undergoing external cephalic version near term. Am J Obstet Gynecol (2000) 0.77
Prenatal sex determination. Lancet (1990) 0.76
Defining the immunogenetic susceptibility to primary biliary cirrhosis. Hepatology (1994) 0.76
Non-invasive prenatal diagnosis. Lancet (1994) 0.76
Circulating cell-free Epstein-Barr virus DNA levels in patients with EBV-associated lymphoid malignancies. Ann N Y Acad Sci (2001) 0.76
Technical optimization of RhD zygosity determination by real-time quantitative polymerase chain reaction: implication for fetal RhD status determination by maternal plasma. Ann N Y Acad Sci (2001) 0.76
On the potential of molecular computing. Science (1995) 0.75
Detection of reactivation and size variation in the regulatory region of JC virus in brain tissue. J Clin Pathol (1993) 0.75
Non-invasive approach to prenatal diagnosis from maternal peripheral blood. Prenat Diagn (1992) 0.75
HLA typing for DR3 and DR4 using artificial restriction fragment length polymorphism PCR from archival DNA. J Clin Pathol (1995) 0.75
C-myc oncogene product p62 in ovarian mucinous neoplasms. J Clin Pathol (1990) 0.75
Dinucleotide repeat polymorphism at the human GLUT2 locus. Nucleic Acids Res (1991) 0.75
Rapid HLA typing by multiplex amplification refractory mutation system. J Clin Pathol (1993) 0.75
More on bear droppings. Nature (1992) 0.75
The 3a Protein of SARS-coronavirus Induces Apoptosis in Vero E6 Cells. Conf Proc IEEE Eng Med Biol Soc (2005) 0.75
Exclusion of false-positive PCR viral diagnosis by single-strand conformation polymorphism. Lancet (1992) 0.75
Circulating fetal DNA in maternal plasma. Clin Chim Acta (2001) 0.75
Molecular genetic analysis of a Chinese patient with Fabry disease. Chin Med J (Engl) (2000) 0.75
Rapid demonstration of Campylobacter in gastric biopsies using microwave irradiation. Med Lab Sci (1989) 0.75
Linkage of maturity-onset diabetes of the young to the glucokinase gene--evidence of genetic heterogeneity. Biochem Soc Trans (1993) 0.75
T3 reverses the changes in met-enkephalin and beta-endorphin contents in the anterior lobe, but not the neuro-intermediate lobe of the pituitary of rats rendered hypothyroid by PTU-treatment. Horm Metab Res (1988) 0.75
Age attenuation in the rat of pituitary-thyroid response to cold. Horm Metab Res (1986) 0.75